Bioorthogonal CRISPR/Cas9‐Drug Conjugate: A Combinatorial Nanomedicine Platform

Bioconjugation of proteins can substantially expand the opportunities in biopharmaceutical development, however, applications are limited for the gene editing machinery despite its tremendous therapeutic potential. Here, a self‐delivered nanomedicine platform based on bioorthogonal CRISPR/Cas9 conju...

Descripción completa

Detalles Bibliográficos
Autores principales: Beha, Marcel Janis, Kim, Joo‐Chan, Im, San Hae, Kim, Yunsu, Yang, Seungju, Lee, Juhee, Nam, Yu Ri, Lee, Haeshin, Park, Hee‐Sung, Chung, Hyun Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520654/
https://www.ncbi.nlm.nih.gov/pubmed/37485817
http://dx.doi.org/10.1002/advs.202302253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520654/
https://www.ncbi.nlm.nih.gov/pubmed/37485817
http://dx.doi.org/10.1002/advs.202302253

Ejemplares similares